Pentachlorophenol

Pentachlorophenol

SCHEMBL997077

C=C.C=C.C=C.C=C.N.Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.77
HPGD P15428 6/20 0.77
HSD17B10 Q99714 6/20 0.77
MEN1 O00255 2/20 0.77
ALDH1A1 P00352 2/20 0.77
LMNA P02545 2/20 0.77
MAPT P10636 2/20 0.77
KMT2A Q03164 2/20 0.77
CYP1A2 P05177 4/20 0.46
CYP2C9 P11712 4/20 0.46
CYP2C19 P33261 1/20 0.46
HIF1A Q16665 3/20 0.46
CASP1 P29466 1/20 0.42
MAPK1 P28482 3/20 0.39
CYP3A4 P08684 3/20 0.36
USP2 O75604 1/20 0.36
TP53 P04637 1/20 0.36
GLA P06280 1/20 0.36
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pentachlorophenol SCHEMBL5998395 1.00 TSHR (0.77) TSHRHPGDHSD17B10MEN1ALDH1A1
Pentachlorophenol SCHEMBL9737316 1.00 TSHR (0.77) TSHRHPGDHSD17B10MEN1ALDH1A1
Pentachlorophenol SCHEMBL2685796 1.00 TSHR (0.77) TSHRHPGDHSD17B10MEN1ALDH1A1
Pentachlorophenol SCHEMBL1665507 0.96 HSD17B10 (0.83) TSHRHPGDHSD17B10MEN1ALDH1A1
Pentachlorophenol SCHEMBL8505797 0.96 HSD17B10 (0.83) TSHRHPGDHSD17B10MEN1ALDH1A1
Pentachlorophenol SCHEMBL8439836 0.96 HSD17B10 (0.83) TSHRHPGDHSD17B10MEN1ALDH1A1
Pentachlorophenol SCHEMBL1249559 0.92 TSHR (0.77) TSHRHPGDHSD17B10MEN1ALDH1A1
Pentachlorophenol SCHEMBL775105 0.92 HSD17B10 (0.91) TSHRHPGDHSD17B10MEN1ALDH1A1
Pentachlorophenol SCHEMBL21177789 0.92 HSD17B10 (0.91) TSHRHPGDHSD17B10MEN1ALDH1A1
Pentachlorophenol SCHEMBL9754589 0.88 HSD17B10 (0.83) TSHRHPGDHSD17B10MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240016709-A1 BIODEGRADABLE MICROCAPSULES. PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2024-01-18 US claimed
EP-4181858-A1 BIODEGRADABLE MICROCAPSULES. PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP Investments LLC (US) 2023-05-24 EP claimed
WO-2022013821-A1 BIODEGRADABLE MICROCAPSULES. PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2022-01-20 WO claimed
CN-106283097-B Cleaning liquid composition 易安爱富科技有限公司 2018-12-04 CN disclosed
US-9982095-B2 Substituted organopolysiloxanes and use thereof PHOSPHONICS LTD (GB) 2018-05-29 US disclosed
CN-106406037-A Photoresist developer 易安爱富科技有限公司 2017-02-15 CN disclosed
CN-106283097-A Cleaning liquid composition 易安爱富科技有限公司 2017-01-04 CN disclosed
US-8377173-B2 Amine absorber for carbon dioxide capture and processes for making and using the same THE UNIVERSITY OF AKRON (US) 2013-02-19 US disclosed
US-8367593-B2 Method for improving the resistance to one or more of corrosion, oxidation, sludge and deposit formation of lubricating oil compositions for biodiesel fueled engines EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2013-02-05 US disclosed
US-8343474-B2 Substituted organopolysiloxanes and uses thereof PHOSPHONICS LTD. (GB) 2013-01-01 US disclosed
EP-2483373-A1 METHOD FOR IMPROVING CORROSION RESISTANCE OF BIODIESEL FUELED ENGINES ExxonMobil Research and Engineering Company (US) 2012-08-08 EP disclosed
US-5543388-A ACETYLENIC ALCOHOLS, QUATERNARY AMMONIUM COMPOUNDS, CINNAMALDEHYDE, IODINE IN NONAQUEOUS SOLVENT EXXON CHEMICAL PATENTS INC. (US) 1996-08-06 US disclosed
US-5516885-A WET STRENGTH AGENTS FOR PAPER AKZO NOBEL N.V. (NL) 1996-05-14 US disclosed
EP-0666242-B1 Electrodialysis treatment EKA NOBEL AB (SE) 1996-03-27 EP disclosed
EP-0666242-A1 Electrodialysis treatment EKA NOBEL AB (SE) 1995-08-09 EP disclosed
EP-0649972-A1 Water flow control in subterranean formation HALLIBURTON COMPANY (US) 1995-04-26 EP disclosed
EP-0638663-A2 Intensified corrosion inhibitor and method of use EXXON CHEMICAL PATENTS INC. (US) 1995-02-15 EP disclosed
US-5358051-A Forming a gel in subsurface formations by injecting a self-crosslinking monomer selected from hydroxy unsaturated carbonyl compounds; decreases water flow HALLIBURTON COMPANY (US) 1994-10-25 US disclosed
EP-0589917-A1 PROCESS FOR PREPARING EPIHALOHYDRIN-BASED RESINS HAVING A REDUCED HALOGEN CONTENT Akzo Nobel N.V. (NL) 1994-04-06 EP disclosed
WO-1992022601-A1 EPIHALOHYDRIN-BASED RESINS HAVING A REDUCED HALOGEN CONTENT AKZO N.V. (NL) 1992-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240016709-A1 BIODEGRADABLE MICROCAPSULES. PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF LIPA, CETP, LIPE TSHR 3900/4885HPGD 1544/4885HSD17B10 1350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.